拓僖联合超液化碘油在肝转移瘤化疗栓塞中的初步应用  

Preliminary application of 10-HCPT combined with lipiodol in TACE for liver metastases

作　　者：黄金华[1] 张亮[1] 范卫君[1] 肖鹏[1] 

机构地区：[1]华南肿瘤学国家重点实验室中山大学肿瘤医院影像介入中心,广州510600

出　　处：《中国肿瘤临床与康复》2006年第3期253-255,共3页Chinese Journal of Clinical Oncology and Rehabilitation

摘　　要：目的探讨对肝转移瘤以拓僖联合超液化碘油进行化疗栓塞(TACE)治疗的安全性与有效性。方法对28例肝转移瘤患者以拓僖为主的化疗药物联合超液化碘油进行化疗栓塞(TA-CE)治疗,评价其临床疗效及毒副反应。结果经拓僖为主的化疗药物联合超液化碘油进行TACE治疗后,总有效率78.6%(22/28)。主要不良反应是骨髓抑制及肝功能损害,以Ⅰ、Ⅱ度为主,其次是发热、恶心呕吐及腹泻。结论以拓僖为主的化疗药物联合超液化碘油进行化疗栓塞(TACE)治疗肝转移瘤是一种安全有效的方法,其不良反应可耐受。Objective To evaluate the effectiveness and safety of 10-HCPT combined with lipiodol in TACE（ transcatheter arterial chemoembolization） for liver metastases. Method A total of 28 cases of liver metastases were treated with TACE mainly with 10-HCPT combined with lipiodol. Results The total response rate was 78.6% （22/28）. The main side-effects included marrow suppression, liver function damage, gastrointestinal reaction and fever. Conclusion TACE mainly with 10-HCPT combined with lipiodol is a safe and effective therapy for the liver metastases, and its side-effect is tolerable.

关 键 词：肝肿瘤 化疗栓塞 拓僖 

分 类 号：R735.7[医药卫生—肿瘤] R730.53[医药卫生—临床医学]